Morbidity and outcome after mechanical ventricular support using thoratec, novacor, and HeartMate for bridging to heart transplantation

被引：49

作者：

Minami, K ^{[1
]}

El-Banayosy, A ^{[1
]}

Sezai, A ^{[1
]}

Arusoglu, L ^{[1
]}

Sarnowsky, P ^{[1
]}

Fey, O ^{[1
]}

Koerfer, R ^{[1
]}

机构：

[1] Ruhr Univ Bochum, Heart Ctr N Rhine Westphalia Bad Oeynhausen, Dept Thorac & Cardiovasc Surg, D-4630 Bochum, Germany

来源：

ARTIFICIAL ORGANS | 2000年 / 24卷 / 06期

关键词：

mechanical ventricular support; bridging to transplantation; Thoratec; Novacor; HeartMate; ventricular assist device;

D O I：

10.1046/j.1525-1594.2000.06621.x

中图分类号：

R318 [生物医学工程];

学科分类号：

0831 ;

摘要：

Between September 1989 and June 1999, 228 patients were supported with a ventricular assist device as a bridge to heart transplantation. In this study, the results of implantation were evaluated in patients supported with one type of device, including 85 supported with a Thoratec, 61 with a Novacor, and 37 with a HeartMate. The mean support time was 49, 148, and 124 days, respectively. Successful transplantation and weaning rates were 64.7% with Thoratec, 59.0% with Novacor, and 62.0% with HeartMate. Cerebral embolism and drive-line and pocket infection were major causes of postoperative morbidity and mortality. We recommended that a Thoratec system be employed as a bridge to heart transplantation for patients with biventricular heart failure, and that a Novacor or HeartMate system be implanted in patients requiring a long-term circulatory support.

引用

页码：421 / 426

页数：6

共 22 条

[1] A fatal mechanical disorder of the TCI HeartMate left ventricular assist system [J].